- Investing Ideas
- /
- South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
SK Biopharmaceuticals
Market Cap: ₩9.4t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩120,400.00
7D
5.1%
1Y
-0.4%
L&C BIOLTD
Market Cap: ₩1.4t
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩58,100.00
7D
10.7%
1Y
217.0%
JW Shinyak
Market Cap: ₩74.1b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,390.00
7D
-1.7%
1Y
5.8%